Full Press Release Details
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint.
BIIB
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint
Key Takeaway: Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint